Racing animals—from Thoroughbred horses to endurance camels—perform at the limits of endurance. Their diets, conditioning programmes and medical support must sustain exceptional workloads while preserving long‑term welfare. Maizer’s Race Collection 2025 embodies this balance. Developed in France under Good Manufacturing Practice (GMP) standards, it includes anabolic and hormonal therapies, corticosteroid formulations, diuretics and energy supplements. These therapies are designed for recovery after illness, transport or intense exertion—not for race‑day enhancement. Anabolic steroids, synthetic derivatives of testosterone, stimulate muscle growth but are banned in competition animals. The Race Collection focuses instead on healing and regulated convalescence within Clean Sport standards.

High‑performance training places extreme strain on muscular and metabolic systems. Horses and camels deplete glycogen stores, accumulate lactate and suffer micro‑trauma. Without adequate recovery, they risk chronic inflammation and reduced immunity. Veterinarians therefore rely on therapies that accelerate repair without breaching doping regulations. The Merck Veterinary Manual notes that anabolic steroids can remain detectable for over two months, demanding careful treatment scheduling. Corticosteroids and diuretics may be allowed under veterinary control but require strict withdrawal periods. The Race Collection is tailored to these boundaries—used during rehabilitation, not as shortcuts to success.